8-year follow-up of a successful outcome of massive pulmonary embolism with cardiogenic shock

Currently pulmonary embolism (PE) is already on the 3rd place in terms of the frequency of occurrence among vascular diseases, and there is a global trend towards an increase in its frequency. PE is also considered as the most common cause of preventable death in the hospital. In the countries of Europe, Asia and the USA, there is a tendency to reduce the cases of fatal PE due to the  use of  more effective conservative therapy, invasive interventions and following the  Recommendations. Since 2019, the European Guidelines for the diagnosis and treatment of PE have made the use of direct oral anticoagulants preferable in comparison with oral vitamin K antagonists.
A case of massive PE in a 42-year-old patient developed in the specialized department of the hospital shortly after being transferred from the intensive care unit with verified PE of small branches (D-dimer, lung scintigraphy, Echo-cardiography) is presented. The debut of a massive PE in the form of a syncopal state with cardiogenic shock, required an urgent transfer of the patient to artificial lung ventilation, the use of vasopressors and systemic thrombolysis. During Echo-cardiography, a mobile blood clot was located in the right atrium. An emergency thrombectomy was performed from the pulmonary trunk and pulmonary arteries in conditions of artificial blood circulation, later a cava filter was installed. The features of anamnesis characteristic of PE (hormonal contraceptives), complaints (sudden shortness of breath, heaviness behind the sternum at admission) and concomitant pathology (drug-induced thyrotoxicosis) are analyzed.
The  results of  the  subsequent 8-year follow-up without relapses of  PE are considered, the  feature of  which was the  use of Rivaroxaban as an anticoagulant and angiovit (B vitamins – 6, 9 and 12) for the correction of hereditary hyperhomocysteinemia. Risk factors and modern standards of treatment of massive PE in the acute period and in the long term are discussed.

1. Konstantinides S.V., Meyer G., Becattini C., Bueno H., Geersing G.J., Harjola V.P. еt al. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS). Eur Respiratory J. 2020;41(4):543–603. https://doi.org/10.1183/13993003.01647-2019.

2. Kearon C., Akl E.A., Ornelas J., Blaivas A., Jimenez D., Bounameaux H. et al. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest. 2016;149(2):315–352. https://doi.org/10.1016/j.chest.2015.11.026.

3. Lobastov K.V. Modern approaches to determining the duration of anticoagulant therapy for venous thromboembolic complication Khirurgiya. Zhurnal im. N.I. Pirogova = Pirogov Russian Journal of Surgery. 2019;(5):94–103. (In Russ.) https://doi.org/10.17116/hirurgia201905194.

4. Konstantinides S.V., Torbicki A. Agnelli G., Danchin N., Fitzmaurice D., Galiè N. et al. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism: the Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC) endorsed by the European Respiratory Society (ERS). Eur Heart J. 2014;35:3033–3069. https://doi.org/10.1093/eurheartj/ehu283.

5. Soboleva E.V. Homocysteinemia as a target of therapeutic effect in patients with coronary heart disease. Effects of simvastatin. RMZh = RMJ. 2007;(2):58–63. (In Russ.) Available at: https://www.rmj.ru/articles/kardiologiya/Gomocisteinemiya_kak_misheny_terapevticheskogo_vozdeystviya_u_ bolynyh_ishemicheskoy_boleznyyu_serdca_Effekty_simvastatina/.

6. Falcon C., Cattaneo M., Panzeri D., Martinelli I., Mannucci P.M. High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. Arterioscler Thromb. 1994;14(7):1080–1083. https://doi.org/10.1161/01.atv.14.7.1080.

7. Hainaut P., Jaumotte C., Verhelst D., Wallemacq P., Gala J.L., Lavenne E. et al. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases. Thromb Res. 2002;106(2):121–125. https://doi.org/10.1016/s0049-3848(02)00096-8.

8. Aujesky D., Roy P.M., Verschuren F., Righini M., Osterwalder J., Egloff M. et al. Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial. Lancet. 2011;378:41–48. https://doi.org/10.1016/S0140-6736(11)60824-6.

9. Brattstrom L., Israelsson B., Jeppson J.- O., Hultberg B.L. Folic acid – an innocuons means to reduce plasma homocysteine. Scand J Clin Lab Invest. 1988;48(3):215–221. https://doi.org/10.3109/00365518809167487.

10. Kuch B., Bobak M., Fobker M., Junker R., von Eckardstein A., Marmot M., Hense H.W. Association between homocysteine and coagulation factors – a cross-sectional study in two populations of Central Europe. Atherosclerosis. 2001;103(4):265–273. https://doi.org/10.1016/s0049-3848(01)00321-8.

11. Den Heijer M., Koster T., Blom H., Bos G.M., Briet E., Reitsma P.H. et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med. 1996;334(12):759–762. https://doi.org/10.1056/NEJM199603213341203.

12. Zondag W., Kooiman J., Klok F.A., Dekkers O.M., Huisman M.V. Outpatient versus inpatient treatment in patients with pulmonary embolism: a meta-analysis. Eur Respir J. 2013;42(1):134. https://doi.org/10.1183/09031936.00093712.

13. Aklog L., Williams C.S., Byrne J.G., Goldhaber S.Z. Acute pulmonary embolectomy: a contemporary approach. Circulation. 2002;105(12):1416. https://doi.org/10.1016/s1062-1458(02)00836-x.

14. Leacche M., Unic D., Goldhaber S.Z., Rawn J.D., Aranki S.F., Couper G.S. et al. Modern surgical treatment of massive pulmonary embolism: results in 47 consecutive patients after rapid diagnosis and aggressive surgical approach. J Thorac Cardiovasc Surg. 2005;129(5):1018–1023. https://doi.org/10.1016/j.jtcvs.2004.10.023.

15. Dauphine C., Omari B. Pulmonary embolectomy for acute massive pulmonary embolism. Ann Thorac Surg. 2005;79(4):1240–1244. https://doi.org/10.1016/j.athoracsur.2004.08.081.

16. McFadden Р.М., Ochsner J.L. Aggressive Approach to Pulmonary Embolectomy for Massive Acute Pulmonary Embolism: A Historical and Contemporary Perspective. Mayo Clin Proc. 2010;85(9):782–784. https://doi.org/10.4065/mcp.2010.0481.

17. Sareyyupoglu B., Greason K.L., Suri R.M., Keegan M.T., Dearani J.A., Sundt T.M. 3rd. A more aggressive approach to emergency embolectomy for acute pulmonary embolism. Mayo Clin Proc. 2010;85(9):785–790. https://doi.org/10.4065/mcp.2010.0250.

18. Takahashi H., Okada K., Matsumori M., Kano H., Kitagawa A., Okita Y. Aggressive surgical treatment of acute pulmonary embolism with circulatory collapse. Ann Thorac Surg. 2012;94(3):785–791. https://doi.org/10.1016/j.athoracsur.2012.03.101.

19. Torbicki A., Perrier A., Konstantinides S., Agnelli G., Galiè N., Pruszczyk P. еt аl. The Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC). Eur Heart J. 2008;29(18):2276–2315. https://doi.org/10.1093/eurheartj/ehn310.

20. Stein P.D. Pulmonary Embolectomy. In: Stein P.D. Pulmonary Embolism. 2nd ed. Wiley; 2008, рp. 459–463. http://doi.org/10.1002/9780470692042.ch93.

21. Rosenberger P., Shernan S.K., Mihaljevic T., Eltzschig H.K. Transesophageal echocardiography for detecting extrapulmonary thrombi during pulmonary embolectomy. Ann Thorac Surg. 2004;78(3):862–866. https://doi.org/10.1016/j.athoracsur.2004.02.069.

22. Vasiltseva O.Ya., Vorozhtsova I.N., Lavrov A.G., Karpov R.S. Thrombi in the right cardiac chambers in patients with pulmonary embolism and atrial fibrillation. Vestnik aritmologii = Journal of Arrhythmology. 2018;(92):16–20. (In Russ.) https://doi.org/10.25760/VA-2018-92-16-20.

23. Stein P.D. Pulmonary Embolectomy. In: Stein P.D. Pulmonary Embolism. 3rd еd. John Wiley & Sons, Ltd; 2016, рp. 626–633. https://doi.org/10.1002/9781119039112.ch121.

24. Vohra H.A., Whistance R.N., Mattam K., Kaarne M., Haw M.P., Barlow C.W. et al. Early and late clinical outcomes of pulmonary embolectomy for acute massive pulmonary embolism. Ann Thorac Surg. 2010;90(6):1747–1752. https://doi.org/10.1016/j.athoracsur.2010.08.002.

25. Kalra R., Bajaj N.S., Arora P., Arora G., Crosland W.A., McGiffin D.C., Ahmed M.I. Surgical Embolectomy for Acute Pulmonary Embolism: Systematic Review and Comprehensive Meta-Analyses. The Annals of Thoracic Surgery. 2017;103(3):982–990. https://doi.org/10.1016/j.athoracsur.2016.11.016.

26. Meneveau N., Séronde M.F., Blonde M.C., Legalery P., Didier-Petit K., Briand F. et al. Management of unsuccessful thrombolysis in acute massive pulmonary embolism. Chest. 2006;129(4):1043–1050. https://doi.org/10.1378/chest.129.4.1043.

27. Cuculi F., Kobza R., Bergner M., Erne P. Usefulness of aspiration of pulmonary emboli and prolonged local thrombolysis to treat pulmonary embolism. Am J Cardiol. 2012;110(12):1841. https://doi.org/10.1016/j.amjcard.2012.07.047.

28. Eid-Lidt G., Gaspar J., Sandoval J., de los Santos F.D., Pulido T., González Pacheco H., Martínez-Sánchez C. et al. Combined clot fragmentation and aspiration in patients with acute pulmonary embolism. Chest. 2008;134(1):54–60. https://doi.org/10.1378/chest.07-2656.

29. Engelberger R.P., Kucher N. Catheter-based reperfusion treatment of pulmonary embolism. Circulation. 2011;124(19):2139–2144. https://doi.org/10.1161/CIRCULATIONAHA.111.023689.